AllianceBernstein’s Tonix Pharmaceuticals TNXP Stock Holding History

AllianceBernstein’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Hold	13,070	–	–	﹤0.01%	3043
2025 Q4	$204K	Hold	13,070	–	–	﹤0.01%	3060
2025 Q3	$316K	Hold	13,070	–	–	﹤0.01%	2920
2025 Q2	$470K	Buy	+13,070	New	+$342K	﹤0.01%	2676
2022 Q2	–	Hold	0	–	-$23K	–	3376
2022 Q1	–	Hold	0	–	–	–	3213
2021 Q4	–	Hold	0	–	–	–	3222
2021 Q3	–	Hold	0	–	–	–	3165
2021 Q2	–	Hold	0	–	–	–	3123

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AllianceBernstein's TNXP Position: Q1 2026 in Review

AllianceBernstein held its Tonix Pharmaceuticals (TNXP) position steady in Q1 2026 at 13,070 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

AllianceBernstein first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $470K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

AllianceBernstein held 13,070 shares of Tonix Pharmaceuticals worth $204K as of Q1 2026.
AllianceBernstein left its Tonix Pharmaceuticals share count unchanged in Q1 2026.
Tonix Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3043 holding.
AllianceBernstein first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
AllianceBernstein's Tonix Pharmaceuticals position peaked at $470K in Q2 2025.
81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.